These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 10397272

  • 1. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers.
    Sgambato A, Migaldi M, Faraglia B, Garagnani L, Romano G, De Gaetani C, Ferrari P, Capelli G, Trentini GP, Cittadini A.
    Cancer Res; 1999 Jul 01; 59(13):3245-50. PubMed ID: 10397272
    [Abstract] [Full Text] [Related]

  • 2. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers.
    Migaldi M, Sgambato A, Garagnani L, Ardito R, Ferrari P, De Gaetani C, Cittadini A, Trentini GP.
    Clin Cancer Res; 2000 Aug 01; 6(8):3131-8. PubMed ID: 10955794
    [Abstract] [Full Text] [Related]

  • 3. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun 01; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
    Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Carrasco JC, Requena MJ, Montironi R.
    Eur Urol; 2004 May 01; 45(5):606-12. PubMed ID: 15082203
    [Abstract] [Full Text] [Related]

  • 5. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI.
    Br J Cancer; 2001 May 04; 84(9):1242-51. PubMed ID: 11336477
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R.
    Am J Clin Pathol; 2004 Sep 04; 122(3):444-52. PubMed ID: 15362377
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
    Kuczyk M, Machtens S, Hradil K, Schubach J, Christian W, Knüchel R, Hartmann J, Bokemeyer C, Jonas U, Serth J.
    Br J Cancer; 1999 Nov 04; 81(6):1052-8. PubMed ID: 10576664
    [Abstract] [Full Text] [Related]

  • 8. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM.
    Cancer Res; 1998 Feb 01; 58(3):542-8. PubMed ID: 9458103
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 01; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
    Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schröder FH, van der Kwast TH.
    J Urol; 2000 Dec 01; 164(6):2156-61. PubMed ID: 11061947
    [Abstract] [Full Text] [Related]

  • 11. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
    Hui AM, Cui X, Makuuchi M, Li X, Shi YZ, Takayama T.
    Hepatology; 1999 Nov 01; 30(5):1167-73. PubMed ID: 10534337
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L, Constantinides C, Papandropoulos J, Theodoropoulos G, Tzonou A, Giannopoulos A, Zervas A, Dimopoulos C.
    Urology; 1995 Sep 01; 46(3):334-40. PubMed ID: 7660508
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A, Ikeda N, Sho M, Tomoda K, Kanehiro H, Hisanaga M, Tsurui Y, Tsutsumi M, Kato JY, Nakajima Y.
    Oncol Rep; 2004 Feb 01; 11(2):277-84. PubMed ID: 14719054
    [Abstract] [Full Text] [Related]

  • 14. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.
    Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein IB.
    Cancer Res; 1998 Jan 01; 58(1):114-22. PubMed ID: 9426067
    [Abstract] [Full Text] [Related]

  • 15. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
    Cheng JD, Werness BA, Babb JS, Meropol NJ.
    Clin Cancer Res; 1999 May 01; 5(5):1057-62. PubMed ID: 10353738
    [Abstract] [Full Text] [Related]

  • 16. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
    Ohtani M, Isozaki H, Fujii K, Nomura E, Niki M, Mabuchi H, Nishiguchi K, Toyoda M, Ishibashi T, Tanigawa N.
    Cancer; 1999 Apr 15; 85(8):1711-8. PubMed ID: 10223564
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Apr 15; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 18. Expression of p27kip1 in prostatic adenocarcinoma.
    Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P.
    Mod Pathol; 1998 Apr 15; 11(4):324-8. PubMed ID: 9578081
    [Abstract] [Full Text] [Related]

  • 19. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D, Blanco C, Friedlander DR, Miller DC, Newcomb EW.
    Hum Pathol; 2003 Jan 15; 34(1):48-53. PubMed ID: 12605366
    [Abstract] [Full Text] [Related]

  • 20. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S, Tamiya T, Ono Y, Abe T, Matsumoto K, Furuta T, Ohmoto T.
    Clin Cancer Res; 1999 Mar 15; 5(3):551-7. PubMed ID: 10100706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.